ampelopsin has been researched along with Colonic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Azami, NLB; Fang, Z; Feng, Y; Li, Q; Sun, M; Sun, X; Wang, Y; Wang, Z; Zhang, L | 1 |
| Liang, J; Wang, F; Wu, J; Zhang, P; Zhang, X | 1 |
| Hui, SC; Kang, C; Lang, HD; Mi, MT; Wang, XL; Yi, L; Zhang, Y; Zhou, M; Zhu, XH | 1 |
3 other study(ies) available for ampelopsin and Colonic Neoplasms
| Article | Year |
|---|---|
Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
Topics: Animals; Apoptosis; Colonic Neoplasms; Colorectal Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonols; HCT116 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; NF-E2-Related Factor 2; NF-kappa B; Oxaliplatin; Signal Transduction; Vincristine | 2021 |
Semaphoring 4D is required for the induction of antioxidant stress and anti-inflammatory effects of dihydromyricetin in colon cancer.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Flavonols; Humans; Male; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Oxidative Stress; Semaphorins | 2019 |
Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models.
Topics: Animals; Chloride Channels; Colonic Neoplasms; Disease Models, Animal; Disease Progression; Drug Synergism; Flavonols; Humans; Irinotecan; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins | 2019 |